Delivery Order SPE2DB22D9130-SPE2DB24FE0CG

Award Date 11/2/23
Potential Completion Date 11/27/23
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at two thousand seven hundred forty dollars and eighty cents ($2,740.80) by the Defense Logistics Agency Troop Support Medical to provide one hundred (100) vials of Botulinum toxin type A. The delivery order was issued against the prime vendor's existing indefinite delivery contract with no set-aside designation used. This contract provides pharmaceutical items and medical supplies with a potential value of...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical pharmaceutical prime vendor contract for $19,185.60 to supply botulinum toxin type A injection. The delivery order was awarded on October 31, 2023 and has a completion date of November 21, 2023. DMS Pharmaceutical Group will provide the botulinum toxin type A injection to Defense Logistics Agency Troop Support Medical facilities located in Park Ridge,...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at fifty thousand ninety-eight dollars and ninety cents ($50,098.90) to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for the delivery of botulinum toxin type A and has a completion date of November 3, 2023. No set-aside designation was used for this procurement. DMS Pharmaceutical Group Inc. will deliver the botulinum toxin to the Defense Logistics Agency as part of its...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-two thousand three hundred forty-two dollars and fifty cents ($32,342.50) by the Defense Logistics Agency Troop Support Medical to provide two hundred (200) vial units of BOTOX. The delivery order was awarded on November second, two thousand twenty-three (November 2, 2023) with a completion date of November twenty-seventh, two thousand twenty-three (November 27, 2023). DMS Pharmaceutical Group...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one thousand eight hundred twenty-seven dollars and twenty-four cents ($1,827.24) by the Defense Logistics Agency to provide one hundred (100) vials of BOTOX containing one hundred (100) units each. The delivery order was awarded on December fourth, two thousand twenty-three against the prime vendor's indefinite delivery contract with the Defense Logistics Agency for pharmaceutical supplies with a...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against an indefinite delivery contract with the Defense Logistics Agency Troop Support Medical to provide $52,532 worth of botulinum toxin type A. The delivery order has a completion date of December 26, 2023 and was awarded on December 6, 2023 without a set-aside designation. DMS Pharmaceutical Group will supply the botulinum toxin from its facilities in Park Ridge, Illinois to Defense Logistics Agency Troop...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at eleven thousand six hundred forty-three dollars and thirty cents ($11,643.30) by the Defense Logistics Agency. The delivery order was awarded on December 4, 2023 and requires completion by December 26, 2023. The delivery order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group with the Defense Logistics Agency to supply various pharmaceutical and medical...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at three thousand six hundred fifty four dollars and forty cents ($3,654.40) by the Defense Logistics Agency (DLA) Troop Support Medical to provide one hundred (100) vials of BOTOX. The delivery order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group with DLA to supply pharmaceuticals and medical supplies with a potential value of up to five million dollars...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $5,481.60 under an indefinite delivery contract with the Defense Logistics Agency to supply 100 unit vials of BOTOX. The delivery order was awarded on December 15, 2023 and has a completion date of January 9, 2024. No set-aside designation was used for this award. DMS Pharmaceutical Group will fulfill the delivery order as the prime contractor, supplying the requested pharmaceutical products to Defense Logistics...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $2,284 to supply 100 unit vials of Botulinum toxin type A to the Defense Logistics Agency Troop Support Medical. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025. Under the contract, DMS Pharmaceutical Group provides various pharmaceutical items and medical...
  • SPE2DB22D9130
    Indefinite Delivery Contract
  • SPE2DB22D9130-SPE2DB24FE0CG
    Delivery Order

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at two thousand seven hundred forty dollars and eighty cents ($2,740.80) by the Defense Logistics Agency Troop Support Medical to provide one hundred (100) vials of Botulinum toxin type A. The delivery order was issued on November second, two thousand twenty-three against the prime vendor's existing indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to five million dollars through December 2025. No set-aside designation was applied to this award. Performance will occur in Park Ridge, Illinois and is scheduled for completion by November twenty-seventh, two thousand twenty-three.

Generated 2/1/24, 10:18 AM